Founder Lodge | A2 Biotherapeutics, Inc. raises $80,000,000 at …

Jan 10, 2025 · A2 Biotherapeutics, Inc. raises $80,000,000 at Series C on 2025-01-10 in Biotechnology Research, industry founded/co-founded by Jim Robinson

CouponFollow Extension

$80000000
OFF

Founder Lodge | A2 Biotherapeutics, Inc. Raises $80,000,000 At …

3 weeks from now

Jan 10, 2025 · A2 Biotherapeutics, Inc. raises $80,000,000 at Series C on 2025-01-10 in Biotechnology Research, industry founded/co-founded by Jim Robinson

founderlodge.com

$80
OFF

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

AGOURA HILLS, Calif., January 09, 2025--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor ...

yahoo.com

$80
OFF

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025 · A2 Biotherapeutics, Inc. (A2 Bio) is a clinical-stage biotech company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers.

businesswire.com

$80
OFF

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025 · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a …

pacbiztimes.com

$80
OFF

A2 Biotherapeutics Raises $80m To Advance CAR-T Therapies For …

3 weeks from now

Jan 10, 2025 · US-based biotech company A2 Biotherapeutics (A2 Bio) has secured $80m in funding to advance its pipeline of chimeric antigen receptor (CAR)-T cell therapies for solid …

yahoo.com

$3
OFF

Founder Lodge | 225+ Founders $3.2B Raised On LinkedIn: A2 ...

3 weeks from now

Founder Lodge | 225+ Founders $3.2B Raised 9,404 followers 2w A2 Biotherapeutics, Inc. raised $80,000,000 in Series C-Congrats Jim Robinson Full Round Info: https://lnkd.in/gwMrZtTE …

linkedin.com

$80000000
OFF

A2 Biotherapeutics, Inc. - Founder Lodge

3 weeks from now

Jan 10, 2025 · A2 Biotherapeutics, Inc. Biotechnology Research, United States - Agoura Hills, CA START UP 1 Disclosed Funding Rounds $80,000,000 0 Participating Investments …

founderlodge.com

$80
OFF

A2 Biotherapeutics Raises $80M Series C Funding - Finsmes.com

3 weeks from now

Jan 9, 2025 · A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

finsmes.com

$80
OFF

A2 Biotherapeutics Funding & Investors - Tracxn

3 weeks from now

Jan 30, 2025 · How much funding did A2 Biotherapeutics raise in its latest funding round? A2 Biotherapeutics raised $80M in its latest funding round, which was Series C round held on Jan …

tracxn.com

$8800000
OFF

Founder Lodge | Biosphere Raises $8,800,000 At Seed On 2025-01-10

3 weeks from now

Jan 10, 2025 · Biosphere raises $8,800,000 at Seed on 2025-01-10 in Manufacturing, industry founded/co-founded by Brian Heligman

founderlodge.com

$80
OFF

A2 Bio Closes $80M Series C Capital Raise - Pacbiztimes.com

3 weeks from now

Jan 17, 2025 · James Robinson, CEO of A2 Biotherapeutics. (courtesy photo) Established in 2018, Agoura Hills-based A2 Biotherapeutics is developing first-in-class logic-gated cell …

pacbiztimes.com

$15000000
OFF

Founder Lodge | Alessa Therapeutics, Inc. Raises $15,000,000 At …

3 weeks from now

Dec 13, 2024 · Alessa Therapeutics, Inc. raises $15,000,000 at Seed on 2024-12-13 in Biotechnology Research, industry founded/co-founded by Pamela N Munster

founderlodge.com

$15000000
OFF

Founder Lodge | RheumaGen Raises $15,000,000 At Series A On …

3 weeks from now

10/01/2025 Series A $15,000,000 RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen …

founderlodge.com

$8412690
OFF

Founder Lodge | Abselion Raises $8,412,690 At Series A On 2024-12 …

3 weeks from now

10/12/2024 Series A $8,412,690 Our mission at Abselion is to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics. Our …

founderlodge.com

$4000000
OFF

Founder Lodge | RyboDyn Inc. Raises $4,000,000 At Pre-Seed On …

3 weeks from now

10/01/2025 Pre-Seed $4,000,000 RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific …

founderlodge.com

$35000000
OFF

Founder Lodge | Air Raises $35,000,000 At Series B On 2025-01-10

3 weeks from now

10/01/2025 Series B $35,000,000 Air is a Creative Ops System for creative teams. Our product automates the mindless tasks that creatives and marketers do every day to manage content …

founderlodge.com

FAQs about Founder Lodge | A2 Biotherapeutics, Inc. raises $80,000,000 at … Coupon?

How does A2 bio work?

A2 Bio aims to address these difficulties with its logic-gated cell therapies, designed to target cancer cells while sparing healthy tissue. This approach uses two receptors: an activator that identifies tumour-specific antigens and a blocker that binds to antigens on normal cells, preventing unintended damage. ...

How does A2 bio's IMOD platform work?

The company’s Imod platform underpins A2 Bio’s cell therapy strategy. The Tmod platform’s dual-receptor design, comprising an activator that targets tumour cells and a blocker for normal cells, addresses the issue with other solid tumour cancer treatments. It acts by selectively targeting tumour cells while sparing healthy ones. ...

Does A2 bio have a CAR-T programme?

A2 Bio has two ongoing Phase I/II clinical trials investigating two of its CAR-T programmes. Credit: THOMAS COEX via Getty Images. ·Pharmaceutical Technology·THOMAS COEX via Getty Images. ...